Skip to Content

1,757 Results Found

  • Article
  • Open Access
18 Citations
4,958 Views
16 Pages

Therapeutic Effect of Rapamycin on Aortic Dissection in Mice

  • Makiko Hayashi-Hori,
  • Hiroki Aoki,
  • Miho Matsukuma,
  • Ryohei Majima,
  • Yohei Hashimoto,
  • Sohei Ito,
  • Saki Hirakata,
  • Norifumi Nishida,
  • Aya Furusho and
  • Yoshihiro Fukumoto
  • + 1 author

Aortic dissection (AD) is a serious clinical condition that is unpredictable and frequently results in fatal outcome. Although rapamycin, an inhibitor of mechanistic target of rapamycin (mTOR), has been reported to be effective in preventing aortopat...

  • Article
  • Open Access
22 Citations
4,013 Views
18 Pages

Mixed Polymeric Micelles for Rapamycin Skin Delivery

  • Guillaume Le Guyader,
  • Bernard Do,
  • Ivo B. Rietveld,
  • Pascale Coric,
  • Serge Bouaziz,
  • Jean-Michel Guigner,
  • Philippe-Henri Secretan,
  • Karine Andrieux and
  • Muriel Paul

Facial angiofibromas (FA) are one of the most obvious cutaneous manifestations of tuberous sclerosis complex. Topical rapamycin for angiofibromas has been reported as a promising treatment. Several types of vehicles have been used hitherto, but polym...

  • Article
  • Open Access
20 Citations
4,491 Views
11 Pages

Genotype and Trait Specific Responses to Rapamycin Intake in Drosophila melanogaster

  • Palle Duun Rohde,
  • Asbjørn Bøcker,
  • Caroline Amalie Bastholm Jensen,
  • Anne Louise Bergstrøm,
  • Morten Ib Juul Madsen,
  • Sandra Læsø Christensen,
  • Steffan Balling Villadsen and
  • Torsten Nygaard Kristensen

20 May 2021

Rapamycin is a powerful inhibitor of the TOR (Target of Rapamycin) pathway, which is an evolutionarily conserved protein kinase, that plays a central role in plants and animals. Rapamycin is used globally as an immunosuppressant and as an anti-aging...

  • Review
  • Open Access
60 Citations
12,803 Views
13 Pages

Mammalian target of rapamycin (mTOR, now referred to as mechanistic target of rapamycin) is considered as the master regulator of cell growth. A definition of cell growth is a build-up of cellular mass through the biosynthesis of macromolecules. mTOR...

  • Review
  • Open Access
41 Citations
5,848 Views
11 Pages

Rapamycin: Drug Repurposing in SARS-CoV-2 Infection

  • Jiri Patocka,
  • Kamil Kuca,
  • Patrik Oleksak,
  • Eugenie Nepovimova,
  • Martin Valis,
  • Michal Novotny and
  • Blanka Klimova

Since December 2019, SARS-CoV-2 (COVID-19) has been a worldwide pandemic with enormous consequences for human health and the world economy. Remdesivir is the only drug in the world that has been approved for the treating of COVID-19. This drug, as we...

  • Article
  • Open Access
7 Citations
7,039 Views
15 Pages

Selective Substitution of 31/42–OH in Rapamycin Guided by an in Situ IR Technique

  • Shuang Cao,
  • Xinbo Zhou,
  • Yuanshuai Yang,
  • Wu Zhong and
  • Tiemin Sun

10 June 2014

An in situ IR technique was applied in the selective synthesis of the key intermediate for rapamycin derivatives, which made the reaction endpoint easily defined. This technology solved a bothersome problem in the preparation of rapamycin derivatives...

  • Article
  • Open Access
23 Citations
5,738 Views
15 Pages

Rapamycin Maintains the Chondrocytic Phenotype and Interferes with Inflammatory Cytokine Induced Processes

  • Andrea De Luna-Preitschopf,
  • Hannes Zwickl,
  • Stefan Nehrer,
  • Markus Hengstschläger and
  • Mario Mikula

Osteoarthritis (OA) is hallmarked by a progressive degradation of articular cartilage. Besides risk factors including trauma, obesity or genetic predisposition, inflammation has a major impact on the development of this chronic disease. During the co...

  • Brief Report
  • Open Access
14 Citations
7,062 Views
11 Pages

18 September 2012

Staphylococcal enterotoxin B (SEB) and related exotoxins produced by Staphylococcus aureus are potent activators of the immune system and cause toxic shock in humans. Currently there is no effective treatment except for the use of intravenous immunog...

  • Article
  • Open Access
5 Citations
4,304 Views
14 Pages

27 January 2022

The MTOR signal is known to be activated in various cancer cells including hepatocellular carcinoma (HCC) cells. Rapamycin, a specific inhibitor of MTOR, has been widely used as an immunosuppressant in organ transplant patients, and its clinical appl...

  • Communication
  • Open Access
11 Citations
9,060 Views
10 Pages

26 March 2015

An antibiotic rapamycin is one of the most commonly used immunosuppressive drugs, and also implicated for its anti-cancer activity. Hence, the determination of its blood level after organ transplantation or tumor treatment is of great concern in medi...

  • Article
  • Open Access
11 Citations
4,500 Views
21 Pages

Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury

  • Qingyu Zhou,
  • Justin Doherty,
  • Antonina Akk,
  • Luke E. Springer,
  • Ping Fan,
  • Ivan Spasojevic,
  • Ganesh V. Halade,
  • Huanghe Yang,
  • Christine T. N. Pham and
  • Hua Pan
  • + 1 author

21 January 2022

Cancer treatment-induced toxicities may restrict maximal effective dosing for treatment and cancer survivors’ quality of life. It is critical to develop novel strategies that mitigate treatment-induced toxicity without affecting the efficacy of...

  • Article
  • Open Access
5 Citations
2,624 Views
15 Pages

Blockade of mTORC1 via Rapamycin Suppresses 27-Hydroxycholestrol-Induced Inflammatory Responses

  • Nakyung Kang,
  • Jaesung Kim,
  • Munju Kwon,
  • Yonghae Son,
  • Seong-Kug Eo,
  • Ninib Baryawno,
  • Byoung Soo Kim,
  • Sik Yoon,
  • Sae-Ock Oh and
  • Koanhoi Kim
  • + 1 author

26 September 2024

Atherosclerosis is characterized by the deposition and accumulation of extracellular cholesterol and inflammatory cells in the arterial blood vessel walls, and 27-hydroxycholesterol (27OHChol) is the most abundant cholesterol metabolite. 27OHChol is...

  • Article
  • Open Access
673 Views
17 Pages

Natural Genetic Variation Impacts Stress-Induced Quiescence and Regeneration in Response to Rapamycin

  • Sahiti Peddibhotla,
  • Miriam Gonzaga,
  • Tricia Zhang,
  • Yasha Goel,
  • Jun Sun,
  • Benjamin R. Harrison,
  • Daniel E. L. Promislow and
  • Hannele Ruohola-Baker

26 January 2026

In response to ionizing radiation (IR), both adult and cancer stem cells enter reversible cell cycle arrest at the G1/S transition to evade apoptosis and subsequently re-enter the cell cycle to regenerate damaged tissue. Entry into and exit from this...

  • Review
  • Open Access
23 Citations
8,903 Views
19 Pages

Resveratrol, Rapamycin and Metformin as Modulators of Antiviral Pathways

  • Francesca Benedetti,
  • Vincenzo Sorrenti,
  • Alessandro Buriani,
  • Stefano Fortinguerra,
  • Giovanni Scapagnini and
  • Davide Zella

17 December 2020

Balanced nutrition and appropriate dietary interventions are fundamental in the prevention and management of viral infections. Additionally, accurate modulation of the inflammatory response is necessary to achieve an adequate antiviral immune respons...

  • Article
  • Open Access
5 Citations
4,552 Views
14 Pages

25 August 2021

Rapamycin is an exogenous compound that has been shown to improve cognition in Alzheimer’s disease mouse models and can regulate pathways downstream of the insulin receptor signaling pathway. Insulin is also known to improve cognition in rodent model...

  • Article
  • Open Access
14 Citations
3,359 Views
17 Pages

Rapamycin Perfluorocarbon Nanoparticle Mitigates Cisplatin-Induced Acute Kidney Injury

  • Qingyu Zhou,
  • James D. Quirk,
  • Ying Hu,
  • Huimin Yan,
  • Joseph P. Gaut,
  • Christine T. N. Pham,
  • Samuel A. Wickline and
  • Hua Pan

For nearly five decades, cisplatin has played an important role as a standard chemotherapeutic agent and been prescribed to 10–20% of all cancer patients. Although nephrotoxicity associated with platinum-based agents is well recognized, treatme...

  • Article
  • Open Access
1,270 Views
16 Pages

Ilex latifolia Improves the Anti-Tumor Effectiveness of Rapamycin Against Breast Cancer In Vitro and In Vivo

  • Zhengnan Ren,
  • Yikuan Wu,
  • Xiaoying Guo,
  • Haizhi Tian,
  • Hongjing Ou,
  • Zihan Xiong,
  • Yu Xiao,
  • Longquan Xiao,
  • Jing Li and
  • Xinhui Wang
  • + 1 author

24 April 2025

Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide. Although the mTOR inhibitor rapamycin exhibits notable anti-tumor activity, its clinical application is limited by metabolic side effects, particularly...

  • Article
  • Open Access
8 Citations
3,741 Views
12 Pages

6 September 2022

Yarrowia lipolytica is an oleaginous yeast for the production of oleochemicals and biofuels. Nitrogen deficiency is beneficial to lipids biosynthesis in Y. lipolytica. Target of rapamycin (TOR) regulates the utilization of nutrients, which is inhibit...

  • Article
  • Open Access
1 Citations
2,629 Views
12 Pages

The Effects of Rapamycin on the Intestinal Graft in a Rat Model of Cold Ischemia Perfusion and Preservation

  • Ibitamuno Caleb,
  • Benedek Kasza,
  • Luca Erlitz,
  • Dávid Semjén,
  • Péter Hardi,
  • Lilla Makszin,
  • Szilárd Rendeki,
  • Ildikó Takács,
  • Tibor Nagy and
  • Gábor Jancsó

25 August 2022

Attenuating the rheological and structural consequences of intestinal ischemia-reperfusion-injury (IRI) is important in transplant proceedings. Preconditioning is an often-proposed remedy. This technique uses physical or pharmacological methods to ma...

  • Article
  • Open Access
3 Citations
2,133 Views
17 Pages

Rapamycin is a polyketide macrocyclic antibiotic with exceptional pharmacological potential. To explore the potential mechanism of rapamycin overproduction, the intracellular metabolic differences of three chemical elicitor treatments were first inve...

  • Article
  • Open Access
644 Views
15 Pages

Rapamycin-Reactivated Lipid Catabolism in Eruca sativa Mill. Exposed to Salt Stress

  • Emilio Corti,
  • Sara Falsini,
  • Gianmarco Patrussi,
  • Nadia Bazihizina,
  • Cristina Gonnelli and
  • Alessio Papini

15 July 2025

Salt stress is one of the most common factors reducing the productivity of crops. We tested the effect of Rapamycin, an mTOR inhibitor and autophagy inducer, for the possible amelioration of high-salinity stress in Eruca sativa. We analyzed the germi...

  • Article
  • Open Access
15 Citations
5,316 Views
23 Pages

Rapamycin Alternatively Modifies Mitochondrial Dynamics in Dendritic Cells to Reduce Kidney Ischemic Reperfusion Injury

  • Maria Namwanje,
  • Bijay Bisunke,
  • Thomas V. Rousselle,
  • Gene G. Lamanilao,
  • Venkatadri S. Sunder,
  • Elizabeth C. Patterson,
  • Canan Kuscu,
  • Cem Kuscu,
  • Daniel Maluf and
  • Amandeep Bajwa
  • + 3 authors

Dendritic cells (DCs) are unique immune cells that can link innate and adaptive immune responses and Immunometabolism greatly impacts their phenotype. Rapamycin is a macrolide compound that has immunosuppressant functions and is used to prevent graft...

  • Communication
  • Open Access
2 Citations
2,195 Views
12 Pages

Structural Insights into the Giardia lamblia Target of Rapamycin Homolog: A Bioinformatics Approach

  • Patricia L. A. Muñoz-Muñoz,
  • Rosa E. Mares-Alejandre,
  • Samuel G. Meléndez-López and
  • Marco A. Ramos-Ibarra

TOR proteins, also known as targets of rapamycin, are serine/threonine kinases involved in various signaling pathways that regulate cell growth. The protozoan parasite Giardia lamblia is the causative agent of giardiasis, a neglected infectious disea...

  • Article
  • Open Access
2,001 Views
20 Pages

Chronic Rapamycin Prevents Electrophysiological and Morphological Alterations Produced by Conditional Pten Deletion in Mouse Cortex

  • Jason S. Hauptman,
  • Joseph Antonios,
  • Gary W. Mathern,
  • Michael S. Levine and
  • Carlos Cepeda

8 January 2025

Abnormalities in the mammalian target of the rapamycin (mTOR) pathway have been implicated in numerous developmental brain disorders. While the molecular and histological abnormalities have been described, less is known about alterations in membrane...

  • Article
  • Open Access
6 Citations
3,630 Views
17 Pages

Amelioration of Diabetic Nephropathy by Targeting Autophagy via Rapamycin or Fasting: Relation to Cell Apoptosis/Survival

  • Khaled Gouda,
  • Sherihan AbdelHamid,
  • Ahmed Mansour,
  • Nesreen Omar and
  • Hala El-Mesallamy

22 October 2021

Autophagy has been demonstrated to have a beneficial effect on diabetic nephropathy (DN). Rapamycin, an inhibitor of mTOR, was shown to stimulate β-cell autophagy. However, its effects on preventing or ameliorating DN is unclear, and its effects are...

  • Article
  • Open Access
21 Citations
3,389 Views
18 Pages

Therapeutic Effect of Rapamycin on TDP-43-Related Pathogenesis in Ischemic Stroke

  • Yi-Syue Tsou,
  • Jing-Huei Lai,
  • Kai-Yun Chen,
  • Cheng-Fu Chang and
  • Chi-Chen Huang

30 December 2022

Stroke is a major cause of death and disability across the world, and its detrimental impact should not be underestimated. Therapies are available and effective for ischemic stroke (e.g., thrombolytic recanalization and mechanical thrombectomy); howe...

  • Article
  • Open Access
12 Citations
6,770 Views
14 Pages

16 June 2015

Glucose transporter isoform-3 (GLUT3), one of the primary placental facilitative glucose transporters responsible for basal glucose transport, has a crucial role in glucose transport and fetal growth during early pregnancy. A GLUT3 mutation in mice h...

  • Article
  • Open Access
2 Citations
3,376 Views
15 Pages

Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer

  • Yu-Hsuan Liu,
  • Ling-Chun Chen,
  • Wen-Ting Cheng,
  • Pu-Sheng Wei,
  • Chien-Ming Hsieh,
  • Ming-Thau Sheu,
  • Shyr-Yi Lin,
  • Hsiu-O Ho and
  • Hong-Liang Lin

In recent years, combining different types of therapy has emerged as an advanced strategy for cancer treatment. In these combination therapies, oral delivery of anticancer drugs is more convenient and compliant. This study developed an irinotecan/rap...

  • Article
  • Open Access
3 Citations
2,682 Views
13 Pages

Neuroblastoma is the most common pediatric solid tumor originating from the neural crest. New treatment options are needed to improve treatment outcomes and the survival of patients with neuroblastoma. Monensin is an ionophore antibiotic with antipar...

  • Article
  • Open Access
18 Citations
4,699 Views
17 Pages

Rapamycin Eyedrops Increased CD4+Foxp3+ Cells and Prevented Goblet Cell Loss in the Aged Ocular Surface

  • Claudia M. Trujillo-Vargas,
  • Shallu Kutlehria,
  • Humberto Hernandez,
  • Rodrigo G. de Souza,
  • Andrea Lee,
  • Zhiyuan Yu,
  • Stephen C. Pflugfelder,
  • Mandip Singh and
  • Cintia S. de Paiva

24 November 2020

Dry eye disease (DED), one of the most prevalent conditions among the elderly, is a chronic inflammatory disorder that disrupts tear film stability and causes ocular surface damage. Aged C57BL/6J mice spontaneously develop DED. Rapamycin is a potent...

  • Article
  • Open Access
44 Citations
9,173 Views
13 Pages

Antitumor Effects of Rapamycin in Pancreatic Cancer Cells by Inducing Apoptosis and Autophagy

  • Zhi-Jun Dai,
  • Jie Gao,
  • Xiao-Bin Ma,
  • Hua-Feng Kang,
  • Bao-Feng Wang,
  • Wang-Feng Lu,
  • Shuai Lin,
  • Xi-Jing Wang and
  • Wen-Ying Wu

21 December 2012

Rapamycin (Rapa), an inhibitor of mammalian target of Rapamycin (mTOR), is an immunosuppressive agent that has anti-proliferative effects on some tumors. This study aims to investigate the effects of Rapa suppressing proliferation of pancreatic carci...

  • Article
  • Open Access
16 Citations
5,123 Views
13 Pages

In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules

  • Serena Vittorio,
  • Rosaria Gitto,
  • Ilenia Adornato,
  • Emilio Russo and
  • Laura De Luca

19 February 2021

Computer aided drug-design methods proved to be powerful tools for the identification of new therapeutic agents. We employed a structure-based workflow to identify new inhibitors targeting mTOR kinase at rapamycin binding site. By combining molecular...

  • Article
  • Open Access
9 Citations
3,170 Views
13 Pages

Effects of Early Exposure of Isoflurane on Chronic Pain via the Mammalian Target of Rapamycin Signal Pathway

  • Qun Li,
  • Reilley Paige Mathena,
  • O’Rukevwe Nicole Eregha and
  • C. David Mintz

15 October 2019

Persistent post-surgical pain (PPSP) is a chronic pain condition, often with neuropathic features, that occurs in approximately 20% of children who undergo surgery. The biological basis of PPSP has not been elucidated. Anesthetic drugs can have lasti...

  • Article
  • Open Access
35 Citations
9,121 Views
16 Pages

Rapamycin-Induced Apoptosis in HGF-Stimulated Lens Epithelial Cells by AKT/mTOR, ERK and JAK2/STAT3 Pathways

  • Fang Tian,
  • Lijie Dong,
  • Yu Zhou,
  • Yan Shao,
  • Wenbo Li,
  • Hong Zhang and
  • Fei Wang

11 August 2014

Hepatocyte growth factor (HGF) induced the proliferation of lens epithelial cells (LECs) and may be a major cause of posterior capsule opacification (PCO), which is the most frequent postoperative complication of cataract surgery. To date, several a...

  • Article
  • Open Access
23 Citations
3,819 Views
20 Pages

Rapamycin-Loaded Polymeric Nanoparticles as an Advanced Formulation for Macrophage Targeting in Atherosclerosis

  • Emanuela Fabiola Craparo,
  • Marta Cabibbo,
  • Alice Conigliaro,
  • Maria Magdalena Barreca,
  • Teresa Musumeci,
  • Gaetano Giammona and
  • Gennara Cavallaro

Recently, rapamycin (Rapa) represents a potential drug treatment to induce regression of atherosclerotic plaques; however, its use requires site-specific accumulation in the vessels involved in the formation of the plaques to avoid the systemic effec...

  • Article
  • Open Access
7 Citations
2,800 Views
11 Pages

25 January 2022

Background: Restenosis after airway stenting needs to be addressed urgently. Rapamycin has been proven to inhibit restenosis elsewhere. This study aimed at observing its effects on the respiratory tract. Methods: CCK-8, wound healing, Transwell and a...

  • Review
  • Open Access
256 Citations
23,762 Views
17 Pages

27 October 2017

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that controls a wide spectrum of cellular processes, including cell growth, differentiation, and metabolism. mTOR forms two distinct multiprotein complexes known as mTOR complex 1...

  • Review
  • Open Access
49 Citations
6,182 Views
29 Pages

4 November 2020

The target of rapamycin (TOR) is an evolutionarily-conserved serine/threonine kinase that senses and integrates signals from the environment to coordinate developmental and metabolic processes. TOR senses nutrients, hormones, metabolites, and stress...

  • Review
  • Open Access
8 Citations
2,862 Views
17 Pages

27 August 2023

The molecular mechanisms that drive circadian (24 h) rhythmicity have been investigated for many decades, but we still do not have a complete picture of eukaryotic circadian systems. Although the transcription/translation feedback loop (TTFL) model h...

  • Article
  • Open Access
5 Citations
2,754 Views
22 Pages

Rapamycin Induces Phenotypic Alterations in Oral Cancer Cells That May Facilitate Antitumor T Cell Responses

  • Amirmoezz Yonesi,
  • Kei Tomihara,
  • Danki Takatsuka,
  • Hidetake Tachinami,
  • Manabu Yamazaki,
  • Amir Reza Younesi Jadidi,
  • Mayu Takaichi,
  • Shuichi Imaue,
  • Kumiko Fujiwara and
  • Makoto Noguchi
  • + 2 authors

Objectives: In this study, we investigated the antitumor immunomodulatory effects of rapamycin in oral cancer. Study Design: We examined the proliferation, apoptosis, and migration of cancer cells and investigated the cell surface expression levels o...

  • Article
  • Open Access
10 Citations
3,838 Views
19 Pages

Target of rapamycin (TOR) is a serine/threonine protein kinase that plays a central regulating role in cell proliferation, growth, and metabolism, but little is known about the TOR signaling pathway in Chlorella sorokiniana. In this study, a Chlorell...

  • Review
  • Open Access
164 Citations
15,141 Views
31 Pages

The phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)-dependent pathway is one of the most integral pathways linked to cell metabolism, proliferation, differentiation, and survival. This pathway is dysregula...

  • Article
  • Open Access
16 Citations
5,916 Views
22 Pages

Dietary Restriction and Rapamycin Affect Brain Aging in Mice by Attenuating Age-Related DNA Methylation Changes

  • Zhilei Yin,
  • Xinpeng Guo,
  • Yang Qi,
  • Pu Li,
  • Shujun Liang,
  • Xiangru Xu and
  • Xuequn Shang

15 April 2022

The fact that dietary restriction (DR) and long-term rapamycin treatment (RALL) can ameliorate the aging process has been reported by many researchers. As the interface between external and genetic factors, epigenetic modification such as DNA methyla...

  • Article
  • Open Access
6 Citations
8,510 Views
17 Pages

12 December 2014

The mammalian target of rapamycin complex 1 (mTORC1) is involved in the cellular transcription and translation processes. The undertaken study characterized the enhancer of mRNA decapping protein 4 (Edc4) as mTORC1 interacting protein. Human T lym...

  • Article
  • Open Access
5 Citations
4,000 Views
15 Pages

19 January 2024

Oral cancer is considered as one of the most common malignancies worldwide. Its conventional treatment primarily involves surgery with or without postoperative adjuvant therapy. The targeting of signaling pathways implicated in tumorigenesis is becom...

  • Article
  • Open Access
19 Citations
4,817 Views
21 Pages

The Energy Sensor AMPKα1 Is Critical in Rapamycin-Inhibition of mTORC1-S6K-Induced T-cell Memory

  • Anjuman Ara,
  • Aizhang Xu,
  • Khawaja Ashfaque Ahmed,
  • Scot C. Leary,
  • Md. Fahmid Islam,
  • Zhaojia Wu,
  • Rajni Chibbar and
  • Jim Xiang

Energy sensors mTORC1 and AMPKα1 regulate T-cell metabolism and differentiation, while rapamycin (Rapa)-inhibition of mTORC1 (RIM) promotes T-cell memory. However, the underlying pathway and the role of AMPKα1 in Rapa-induced T-cell memor...

  • Article
  • Open Access
371 Views
9 Pages

9 December 2025

Objective: This study investigated whether rapamycin could modulate the polarisation of CD4+ T cells towards TH1, TH2, TH17, and Treg cells using peripheral blood mononuclear cell (PBMC) obtained from patients with granulomatosis with polyangiitis an...

  • Review
  • Open Access
71 Citations
17,357 Views
27 Pages

19 June 2013

The mechanistic Target of Rapamycin (mTOR) is an evolutionarily conserved serine/threonine kinase which is a member of the PI3K related kinase (PIKK) family. mTOR emerged as a central node in cellular metabolism, cell growth, and differentiation, as...

  • Article
  • Open Access
1 Citations
2,986 Views
12 Pages

Bioinformatic Analysis of Two TOR (Target of Rapamycin)-Like Proteins Encoded by Entamoeba histolytica Revealed Structural Similarities with Functional Homologs

  • Patricia L. A. Muñoz-Muñoz,
  • Rosa E. Mares-Alejandre,
  • Samuel G. Meléndez-López and
  • Marco A. Ramos-Ibarra

28 July 2021

The target of rapamycin (TOR), also known as FKBP-rapamycin associated protein (FRAP), is a protein kinase belonging to the PIKK (phosphatidylinositol 3-kinase (PI3K)-related kinases) family. TOR kinases are involved in several signaling pathways tha...

  • Review
  • Open Access
8 Citations
6,055 Views
15 Pages

The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies

  • Roberto Gambari,
  • Cristina Zuccato,
  • Lucia Carmela Cosenza,
  • Matteo Zurlo,
  • Jessica Gasparello,
  • Alessia Finotti,
  • Maria Rita Gamberini and
  • Marco Prosdocimi

2 September 2023

In this review article, we present the fascinating story of rapamycin (sirolimus), a drug able to induce γ-globin gene expression and increased production of fetal hemoglobin (HbF) in erythroid cells, including primary erythroid precursor cells...

of 36